Aims & Scope ::: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

ISSN: 2212-7046 (Online)
ISSN: 2212-7038 (Print)


Volume 2, 2 Issues, 2015


Download PDF Flyer




Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

This journal supports open access

Aims & ScopeAbstracted/Indexed in




Editor-in-Chief:
Giovanni Passalacqua
Department of Internal Medicine, Allergy & Respiratory Diseases
University of Genova
Genova
Italy


View Full Editorial Board

Purchase Articles Order Reprints

Aims & Scope

Clinical Anti-Inflammatory & Anti-Allergy Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-inflammatory & anti-allergy agents. Clinical studies of new reported anti-inflammatory & anti-allergy drugs include Phase 1 – IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and to pharmacologists.

Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science